Carbone, C.; Piro, G.; Tamburrino, A.; Mina, M. M.; Zanini, S.; Tortora, G.; Melisi, D. TGF-β-Activated Kinase 1 (TAK1) Is an In Vivo Druggable Target for Reverting Pancreatic Cancer Chemoresistance. JOP. J Pancreas (Online) 2013, 14, 562.